Actuate Therapeutics, Inc.
ACTU • XNAS
Actuate Therapeutics, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Daniel Schmitt, with a market cap of $51.0M.
CEODaniel Schmitt
Next Earnings
Upcoming earnings announcement for Actuate Therapeutics, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.19
Earnings History
Past 6 earnings reports for Actuate Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.25Est: -$0.27 | +7.4% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.30Est: -$0.27 | -11.1% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.32Est: -$0.27 | -18.5% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.54Est: -$0.30 | -80.0% | - | — | — |
| Nov 13, 2024 | Q3 2024 | -$0.55 | — | - | — | 10-Q |
| Sep 24, 2024 | Q2 2024 | -$4.20 | — | - | — | 10-Q |